119 related articles for article (PubMed ID: 23672049)
41.
Sangoi MG; Lamothe SM; Guo J; Yang T; Li W; Avery EG; Fisher JT; Zhang S
Mol Pharmacol; 2017 Aug; 92(2):162-174. PubMed ID: 28495999
[TBL] [Abstract][Full Text] [Related]
42. Clemastine, a conventional antihistamine, is a high potency inhibitor of the HERG K+ channel.
Ridley JM; Milnes JT; Hancox JC; Witchel HJ
J Mol Cell Cardiol; 2006 Jan; 40(1):107-18. PubMed ID: 16288909
[TBL] [Abstract][Full Text] [Related]
43. Arrhythmogenicity of Anti-Ro/SSA Antibodies in Patients With Torsades de Pointes.
Lazzerini PE; Yue Y; Srivastava U; Fabris F; Capecchi PL; Bertolozzi I; Bacarelli MR; Morozzi G; Acampa M; Natale M; El-Sherif N; Galeazzi M; Laghi-Pasini F; Boutjdir M
Circ Arrhythm Electrophysiol; 2016 Apr; 9(4):e003419. PubMed ID: 27030700
[TBL] [Abstract][Full Text] [Related]
44. Fluconazole inhibits hERG K(+) channel by direct block and disruption of protein trafficking.
Han S; Zhang Y; Chen Q; Duan Y; Zheng T; Hu X; Zhang Z; Zhang L
Eur J Pharmacol; 2011 Jan; 650(1):138-44. PubMed ID: 20951697
[TBL] [Abstract][Full Text] [Related]
45. Papaverine, a vasodilator, blocks the pore of the HERG channel at submicromolar concentration.
Kim YJ; Hong HK; Lee HS; Moh SH; Park JC; Jo SH; Choe H
J Cardiovasc Pharmacol; 2008 Dec; 52(6):485-93. PubMed ID: 19034039
[TBL] [Abstract][Full Text] [Related]
46. The action of a novel fluoroquinolone antibiotic agent antofloxacin hydrochloride on human-ether-à-go-go-related gene potassium channel.
Guo J; Han SN; Liu JX; Zhang XM; Hu ZS; Shi J; Zhang LR; Zhao ZZ; Zhang Z
Basic Clin Pharmacol Toxicol; 2010 Aug; 107(2):643-9. PubMed ID: 20662825
[TBL] [Abstract][Full Text] [Related]
47. Electrophysiological evaluation of an anticancer drug gemcitabine on cardiotoxicity revealing down-regulation and modification of the activation gating properties in the human rapid delayed rectifier potassium channel.
Wei M; Wang P; Zhu X; Morishima M; Liu Y; Zheng M; Liu G; Osanai H; Yoshimura K; Kume S; Kurokawa T; Ono K
PLoS One; 2023; 18(2):e0280656. PubMed ID: 36730356
[TBL] [Abstract][Full Text] [Related]
48. Mouse ERG K(+) channel clones reveal differences in protein trafficking and function.
Lin EC; Moungey BM; Lim E; Concannon SP; Anderson CL; Kyle JW; Makielski JC; Balijepalli SY; January CT
J Am Heart Assoc; 2014 Dec; 3(6):e001491. PubMed ID: 25497881
[TBL] [Abstract][Full Text] [Related]
49. Cyclovirobuxine D inhibits the currents of HERG potassium channels stably expressed in HEK293 cells.
Zhao J; Wang Q; Xu J; Zhao J; Liu G; Peng S
Eur J Pharmacol; 2011 Jun; 660(2-3):259-67. PubMed ID: 21497594
[TBL] [Abstract][Full Text] [Related]
50. Altering extracellular potassium concentration does not modulate drug block of human ether-a-go-go-related gene (hERG) channels.
Limberis JT; Su Z; Cox BF; Gintant GA; Martin RL
Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1059-65. PubMed ID: 17042915
[TBL] [Abstract][Full Text] [Related]
51. hERG 1b is critical for human cardiac repolarization.
Jones DK; Liu F; Vaidyanathan R; Eckhardt LL; Trudeau MC; Robertson GA
Proc Natl Acad Sci U S A; 2014 Dec; 111(50):18073-7. PubMed ID: 25453103
[TBL] [Abstract][Full Text] [Related]
52. Effects of injectable HPβCD-diclofenac on the human delayed rectifier potassium channel current in vitro and on proarrhythmic QTc in vivo.
Carr DB; McDonnell Moorehead T; Bouchard A; Sprenger CR; Hamilton DA; Lang E; Madden D; Lacouture PG; Wright C
Clin Ther; 2013 May; 35(5):646-58. PubMed ID: 23578606
[TBL] [Abstract][Full Text] [Related]
53. Muscarinic receptor activation increases hERG channel expression through phosphorylation of ubiquitin ligase Nedd4-2.
Wang T; Hogan-Cann A; Kang Y; Cui Z; Guo J; Yang T; Lamothe SM; Li W; Ma A; Fisher JT; Zhang S
Mol Pharmacol; 2014 Jun; 85(6):877-86. PubMed ID: 24688054
[TBL] [Abstract][Full Text] [Related]
54. [Erythromycin inhibits the proliferation of HERG K+ channel highly expressing cancer cells and shows synergy with anticancer drugs].
Chen SZ; Zhang SH; Gong JH; Zhen YS
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(47):3353-7. PubMed ID: 17313833
[TBL] [Abstract][Full Text] [Related]
55. Dimethyl sulfoxide effects on hERG channels expressed in HEK293 cells.
Du X; Lu D; Daharsh ED; Yao A; Dewoody R; Yao JA
J Pharmacol Toxicol Methods; 2006; 54(2):164-72. PubMed ID: 16782359
[TBL] [Abstract][Full Text] [Related]
56. Pentamidine reduces hERG expression to prolong the QT interval.
Cordes JS; Sun Z; Lloyd DB; Bradley JA; Opsahl AC; Tengowski MW; Chen X; Zhou J
Br J Pharmacol; 2005 May; 145(1):15-23. PubMed ID: 15711592
[TBL] [Abstract][Full Text] [Related]
57. C-terminal HERG (LQT2) mutations disrupt IKr channel regulation through 14-3-3epsilon.
Choe CU; Schulze-Bahr E; Neu A; Xu J; Zhu ZI; Sauter K; Bähring R; Priori S; Guicheney P; Mönnig G; Neapolitano C; Heidemann J; Clancy CE; Pongs O; Isbrandt D
Hum Mol Genet; 2006 Oct; 15(19):2888-902. PubMed ID: 16923798
[TBL] [Abstract][Full Text] [Related]
58. Impact of the whole-cell patch-clamp configuration on the pharmacological assessment of the hERG channel: trazodone as a case example.
Rodriguez-Menchaca AA; Ferrer T; Navarro-Polanco RA; Sanchez-Chapula JA; Moreno-Galindo EG
J Pharmacol Toxicol Methods; 2014; 69(3):237-44. PubMed ID: 24412489
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of HERG potassium channel current by the class 1a antiarrhythmic agent disopyramide.
Paul AA; Witchel HJ; Hancox JC
Biochem Biophys Res Commun; 2001 Feb; 280(5):1243-50. PubMed ID: 11162661
[TBL] [Abstract][Full Text] [Related]
60. Block of HERG current expressed in HEK293 cells by the Na+-channel blocker cibenzoline.
Hiramatsu M; Wu LM; Hirano Y; Kawano S; Furukawa T; Hiraoka M
Heart Vessels; 2004 May; 19(3):137-43. PubMed ID: 15168062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
